5th Annual UCHMC Research Symposium (Virtual Meeting)
Thursday, October 1, 2020 9:30 AM - 5:00 PM (Pacific Time) - Not for CME
Friday, October 2, 2020 7:30 AM - 5:30 PM (Pacific Time) - CME
The University of California Hematologic Malignancies Consortium (UCHMC) is a collaboration across the five University of California Cancer Centers to conduct multicenter investigator-initiated clinical trials in a more efficient and effective manner. The annual UCHMC research symposium is formatted to highlight the research being conducted across the UC system.
The 5th Annual UCHMC Research Symposium will include discussions on opportunities for collaboration across the UC system, translating recent laboratory discoveries into new therapies, application of novel therapies in hematologic malignancies, and ongoing clinical trials currently being conducted by the UC Hematologic Malignancies Consortium.
The research symposium will provide attendees with information regarding current research in the field and application of novel therapies, allowing those in attendance to better serve their patient population.
The objective of this meeting are to gain an understanding of how basic research discoveries are being translated into clinical trials, gain a better understanding of best practice in the management of hemtologic malignancies and to become familiar with targeted and immunotherapeutic appproaches for the treatment of hematologic malignancies.
Thursday, October 1, 2020 (Not for CME): Disease team meetings will be held during the day for members of the academic community. At 4:30 PM a UCHMC Disease team-wide meeting will be held for industry participants.
Friday, October 2, 2020 (CME credit available): Presentations from members of the UC community will be held throughout the day.
Location:
Virtual Log-in information to be provided to those who register
For additional information, please visit www.UCHMC.org
We look forward to your participation in our 5th Annual UCHMC Research Symposium.
